Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

PeptimAIze: Revolutionazing Peptide Design through Multi-Property Optimization and Explainable AI

Project description

Innovative deep learning model for efficient peptide design

Protein-protein interactions (PPIs) are vital to many physiological and pathological processes in the human body, making them promising targets for treating diseases such as bacterial infections and cancer. However, the therapeutic use and discovery of peptides are hindered by unfavourable physicochemical properties and inefficient, resource-intensive methods. Supported by the Marie Skłodowska-Curie Actions programme, the PeptimAIze project will develop a deep learning model specialised in generating therapeutic peptides to inhibit PPIs. To achieve this, the project will address gaps in current deep learning approaches to peptide design by developing, a model with improved interpretability. This model will overcome existing limitations while being more efficient and accessible.

Objective

PeptimAIze aims to develop a deep learning model capable of generating therapeutic peptides for inhibiting protein-protein interactions (PPIs). Many PPIs are essential to key physiological and pathological processes, making these interactions ideal targets for selective intervention in several human diseases, including cancer and bacterial infections. However, the therapeutic potential of peptides is often limited by unfavorable physicochemical properties, such as low solubility and poor bioavailability. Current peptide discovery approaches are time- and resource-intensive, generating significant waste through iterative and labour-intensive screening of compound batches across multiple optimisation rounds to experimentally achieve the desired physicochemical properties. While deep learning and generative models have recently emerged for on-demand peptide design, most focus on a single aspect, typically binding affinity, disregarding physicochemical properties and experimental validation. PeptimAIze addresses these gaps by developing a multi-objective deep learning model based on protein language processing that designs peptides by co-optimising binding to the target and the physicochemical properties necessary for optimal administrability and bioavailability. The model will incorporate explainable AI techniques to enhance interpretability and reveal which amino acids in the peptide sequence are associated with the tuning of each considered property. A key step will be the wet-lab validation of the model on targets responsible for vital bacterial functions (Doc/Phd) and cancer development (p53/MDM2 and Bcl-xL/Bak), demonstrating real-world lab applicability. To maximise impact and usability, the model will be deployed through an intuitive, user-friendly app, enabling researchers in academia and industry to design peptides with tailored properties.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
Net EU contribution
€ 260 347,92
Address
SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
SW7 2AZ London
United Kingdom
Region
London Inner London — West Westminster
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data